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EXPRESSION OF MURINE LEUKEMIA VIRUS ENVELOPE
GLYCOPROTEIN gp69/71 ON MOUSE THYMOCYTES
Evidence for Two Structural Variants Distinguished by Presence
Vs. Absence of G, x Antigen*
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BOYSE
(From the Memorial Sloan-Kettering Cancer Center, New York 10021, and the Department of
Microbiology, University of Texas, Southwestern Medical School, Dallas, Texas 75235)
The G, x antigen is found on the thymocytes of some mouse strains (G,,,+) and not of
others (G, -) (1) . It is detected by the cytotoxicity assay in which G,X+ thymocytes are
lysed by G,x antibody and complement . G,x belongs to the "T-cell differentiation
antigens," so-called because they are predominantly or exclusively expressed on T cells,
including thymocytes . These antigens,-including Thy-1, TL, and the Ly set (loci on
chromosomes 6, 9, 17, 19, and elsewhere) -imply a group of genes selectively concerned
with T-cell surface composition (2) .
But G, x is further distinguished by an association with murine leukemia virus (MuLV)
(1), although mice of the prototype G, X+ strain 129 are not life-long producers of
demonstrable MuLV (as for example are AKR mice) . Thus, productive infection with
MuLV frequently causes cells of inherited G, -genotype and of non-T-differentiatioe
pathways to express G , Therefore the presence of G, x on 129 thymocytes might be
viewed as an MuLV-coded character whose expression is geared to the regulatory system
for T-cell differentiation . In the progeny of crosses between 129 and mice of G,- strains,
the segregation of G, x is mendelian, and one outcome of such genetic studies was the
establishment of two congenic strains, 129-G, x - and C57BL/6-G, + (B6-G, x +), which
with their two respective partner strains 129 (G,x + thymocytes) and B6 (G,x - thymo-
cytes form a valuable quartet for studies of G , (3) . The hypothesis that G , thymocyte
antigen is coded by MuLV was recently strengthened by evidence that G,x antigen is a
feature of gp69/71, the major glycoprotein of the MuLV envelope. This conclusion rested
on serological and biochemical data signifying that G, x antigen, which is found free in the
serum as well as on the cell surface, was always inseparable from the intact gp69/71
macromolecule (4, 5).
We report here that gp69/71 occurs on the thymocytes of many mice that do
not express G, x . From this we conclude that MuLV gp69/71 is a surface constit-
uent of thymocytes of most mouse strains, and that Gix antigen distinguishes a
sub-set or allele of the mouse's inventory of genes for specifying this structural
component of MuLV.
Technical considerations: (a) The well-known antiserum (W/Fu x BN)F, ant-W/
Fu(C58NT)D ("anti-NTD"), which has played a conspicuous part in MuLV studies since
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its first description in 1966 (6), is produced by inbred rats immunized against a syngeneic
rat leukemia induced by MuLV. When used in the cytotoxicity assay against intact viable
129 thymocytes it identifies the antigen G,x (named originally for its association with
"Gross-type" [G] MuLV and with Linkage Group IX of the mouse) which we now regard
as a feature of the gp69/71 envelope protein of MuLV (4, 5) . In Ouchterlony and other tests
with disrupted virions or extracts of MuLV-infected cells, anti-NTD recognizes a variety
of MuLV antigens situated on the same or different components of MuLV (6) . No method
of producing anti-G, serum free of antibodies to other MuLV components has yet been
devised; so the serological specificity of the G, x system (cytotoxicity assay) depends on the
use of anti-NTD with 129 thymocytes as the indicator cells, other cellsbeingtyped G,x+ or
G, x- according to their capacity to absorb cytotoxic activity in this test-system (1) . A
salient feature of the Gix typing method is that it relates exclusively to antigen that is
available on the intact cell surface for reaction with antibody; antigen on some other part
of the same gp69/71 molecule might be inaccessible to the respective antibody unless the
plasma membrane were first disrupted. (b) The second technique that is crucial to the
following study involves labeling the intact cell surface with radioactive iodine, followed
by solution of the cell with the detergent Nonidet P-40 (NP-40) . Reaction with the selected
antibody is carried out afterwards, (the antigen-antibody complex then being precipitated
by addition of anti-immunoglobulin serum) . Thus, in this test system the detection of
antigen is not limited by accessibility on the intact cell surface. To take a relevant
example, the anti-NTD which detects G,x in the cytotoxicity assay may also contain
antibody to other gp69/71 antigens that are so-placed that they are free to react in the
second procedure (membrane disrupted) but not in the first (membrane intact) . And
similarly, according to this model, if the gp69/71 component in the plasma membrane of a
particular cell lacked G,x then anti-NTD could give a positive reaction for gp69/71 in the
second assay but not in the first . The iodine-labeling technique, like the cytotoxicity
assay, detects only components of the cell surface, for only these are available for labeling
on the intact cell.
These considerations are more than simply methodological, for they bear on
how glycoproteins like gp69/71 are incorporated in the cell's outer membrane or
in the virion envelope, and so have immunological and other implications .
Materials and Methods
Labeling of viable thymocytes with I'll, followed by immunoprecipitation and sodium dodecyl
sulfate-polyacrylamide gel electrophoreis (SDS-PAGE), and labeling of thymocytes and virus with
['H]-glucosamine are described elsewhere (5) .
Goat anti-Rauscher-MuLV gp69/71, (anti-gp69/71), was prepared by immunizing a goat with the
gp69/71 component of Rauscher-MuLV isolated by phosphocellulose chromatography and Sephadex
gel filtration (this serum was generously supplied by M. Strand and J. T. August, Albert Einstein
College of Medicine, Bronx, N . Y.) . (7) . Anti-NTD (6), pig antigoat Ig, and rabbit antirat Ig were also
used.
Results and Discussion
The thymocytes of various mouse strains were assayed for presence of gp69/71
(envelope glycoprotein of MuLV) in the plasma membrane by '25I labeling of the
intact thymocyte surface, followed by: (a) NP-40 lysis and clearing by low-speed
centrifugation, (b) reaction with anti-gp69/71, (c) precipitation with pig antigoat
1g, and (d) SDS-PAGE. The characteristic peak of gp69/71, which serves as the
basis of the assay, was shown in Fig. 4 of reference 5. We cannot review here the
evidence that anti-gp69/71, made by immunization with gp69/71 purified from
virions, detects exclusively MuLV-gp69/71 and not any other cell surface520
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Typing of Various Inbred and Congenic Mouse Strains for gp69/71 on the Surface of
Thymocytes*
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' All mice were about 2-mo old, andwere bred in our Sloan-Kettering colonies.
$"'I-lactoperoxidase-label immunoprecipitation method: (+) indicates presence, and (-) absence, of the
characteristic gp69/71 peak on SDS-PAGE (see e.g., Fig. 1). For evidence that this is MuLV-gp69/71, and that
both anti-pg69/71 and anti-NTD recognizethe same macromolecule, seereferences 4 and5.
§ Many G,X+ mouse strains fall intothreecategories depending on howmuch G,x antigen their thymocytesexpress,
according to quantitative absorption data (1). G,x' strains express approximately one-third, andG,.' two-thirds,
of the amount on G,x' (prototype 129) strains. G,.-positive strains which do not fit these categories closely, or
have not been adequately tested by quantitative absorption, are recorded as G,X+.
11 Congenic mouse strain produced and bred at Sloan-Kettering.
TMutant subline described by Stocked et a). (3).
glycoprotein; this rests particularly on lack of any reaction with uninfected
control cells, even in the highly sensitive radioimmunoassay (7).
The results are summarized in Table 1, and our conclusions are: (a) gp69/71 is
demonstrable, with anti-gp69/71, on the thymocytes of all strains whose
'thymocytes are known to be Gix+, and also on several strains whose thymocytes
are G,x-. (b) When anti-NTD was substituted for anti-gp69/71 in the same
procedure (final column of Table I) the results were invariably concordant with
anti-gp69/71. Thus anti-NTD serum, which in the cytotoxicity assay identifies a
restricted (G, x+) set ofmice with gp69/71+ thymocytes, identifies allstrains with
gp69/71+ thymocytes, when this antiserum is used intheiodine-labeling method.
We infer that anti-NTD contains antibody to group specific (gs) antigen of
gp69/71 as well as antibody to G, x, the latter now appearing as a type specificity
ofgp69/71. We can account for the virtual lack ofcytotoxicity of (rat) anti-NTD
on G,x-:gp69/71+ thymocytes, as well as of (goat) anti-gp69/71 on thymocytes of
all mouse strains (4), by assuming that the anti-gs-gp69/71 activity of both
antisera is directed to gs antigensites that arerelatively inaccessible inthe intact
plasma membrane (see introductory comments above) . (It is immaterial in this
context whether the two antisera recognize the sameor different gs specificites of
gp69/71.) This interpretation is favored in unpublished experiments performed
by Obata and Tung in which anti-NTD, from which anti-G, activity (cytotoxic-
ity assay) had been removed by absorption with intact G,x+ thymocytes, was
Thymocytes of:
Known G,x type
(cytotoxicity assay
with anti-NTD)
gp69/71 demonstrable$ with:
anti-gp69/71 anti-
NTD
TheG,x congenic strains
129 G,x'§ + +
129-G,x- G,x- _ -
B6 G,x
- + +
B6-G,x+ G,x' + +
Other mouse strains
ARK, C58, A, A-TL- II G,x' + +
C3H/An, DBA/2 G,x' + +
C57BR-G,x+M$, NZB, B6-G,x+M4 G,x+ + +
C3HfBi G,x- to G,x+ + +
In adult life
C57L, B6-Ly-2.111, B6-H-2` G,x_ + +
C57BR, B6-Ly-2.1/Lv-3,111 G,x- Nottested +
B6-TL+11
BALB/c, NIH-Swiss (random bred) G,x-
HSFS-Swiss (inbred)TUNG ET AL.
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FiG. 1 . Coelectrophoresis of ['H-]gp69/71 of Gross-MuLV (-, standard), with [`z°I-]gp69/71
(---) precipitated by anti-gp69/71 from NP-40 lysates of thymocytes. Thymocytes from 129
mice (A), B6 (B), or B6-G I,, I congenic mice (C) . Anode on the right. Electrophoresis at 2.5
V/cm for 24 h at room temperature in 7 .5% gels. This figure shows one of three such
experiments, all of which gave identical results.
still active in detecting gp69/71 in the 1251-immunoprecipitation assay; this we
attribute to the disruption of the plasma membrane before reaction with gs
antibody. (c) The phenotype of the B6 thymocyte is specially relevant to the
postulate of two gp69/71 variants, one bearing G,x antigen and the other not,
becausethe two congenic strains B6-G, x+ and 129-G,- were both derivedfrom a522
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cross between B6 and 129 mice. The gp69/71+ phenotype of 136 thymocytes tells
us that if both G, x -gp69/71 and GIx+gp69/71 molecules are coded by chromo-
somally integrated MuLV genomes, then these two gp69/71 genes belong to
different loci that are not closely linked to each other. This follows from the fact
that thymocytes of 129-G, x- mice are G, x
-:gp69/71 - whereas B6 thymocytes
are GIx-:gp69/71+. If the B6 G, -gp69/71 locus were closely linked to the
GI x+-gp69/71 locus it would have been introduced into the 129 stock during the
serial backcrosses used to produce the 129-G, x- congenic stock, and the latter's
thymocytes would be G, x -:gp69/71+, which they are not; they are GIx --
gp69/71-. (d) The corollary is that thymocytes of the B6-G,x+ congenic
stock should carry both species of gp69/71 molecule. Fig. 1 supports this by
indicating that 129 and 136 thymocytes carry physically distinguishable gp69/71
components, and that thymocytes of congenic B6-G,x+ mice carry both. Fig. 1 A,
B, and C shows SDS-PAGE patterns for thymocytes of 129, B6, and B6-G, x+
mice, respectively . The standard (solid line) in each case is [3H]-glucosamine-
labeled Gross-MuLV-gp69/71 added to the "5I-labeled thymocyte immuno-
precipitates for coelectrophoresis. The gp69/71 component of 129 runs slightly in
front of the standard (Fig. 1 A) and that of B6 somewhat behind (Fig. 1 B),
whereas the gp69/71 peak of B6-GIx + straddles the standard (Fig. 1 C),
suggesting that it comprises both GIx+gp69/71 (129) and G, x-gp69/71 (B6)
components. (The experiment shown in Fig. 1 has been repeated twice, and the
same differences in mobility were observed in both.) This accords with the
higher titer of gp69/71 antigen recorded by Stockert et al . (3) for B6-G,,'
thymocytes as compared with either 129 or 136, and with radioimmunoassay
measurements forspleen of these three strains (8, 9) .
Two reports of close relevanceto this study refer (a) to the presence of gp69/71 in spleen
ofthree members of the "G,x quartet," and its absence from the fourth, 129-G, x- (8, 9), as
we report here for thymocytes, and (b) to other evidence implying structural variation of
MuLV-gp69/71 (10) .
Summary
Thymocytes of several mouse strains were tested for expression of the gp69/71
envelope component of murine leukemia virus by surface iodination, followed by
immunoprecipitation and sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis. These strains included two congenic lines differing from their
partner stocks with respect to expression of G,x antigen demonstrable in the
cytotoxicity assay. We conclude that: (a) two structural variants of gp69/71 can
be expressed on mouse thymocytes, (b) these are distinguishable by a small
difference in mobility in SDS gels, (c) one carries GIx antigen and the other not,
(d) they are coded, or their expression is regulated, by different chromosomal
loci that are not closely linked, and (e) both can be expressed together on the
thymocytes of inbred mice . In the intact thymocyte plasma membrane, the sites
of group-specific antigen shared by the two gp69/71 variants, unlike the G,x type
specificity carried by only one of them, are probably inaccessible to antibody.
We thank Dr. F. Lilly for a timely suggestion regarding the segregation genetics, now published (8),
Dr. E. Stockert for the anti-NTD, Doctors M. Strand and J. T. August for anti-gp69/71, Dr. R.Wilsnack for pig antigoat Ig, Dr. U. Hammerling for rabbit antirat Ig, and Mrs. J. Seguin for valued
technical assistance.
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